Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelmnews2024-01-31T19:10:58+00:00January 31st, 2024|The New York Times|
A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicinenews2023-12-25T14:00:10+00:00December 25th, 2023|The New York Times|
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Researchnews2023-12-25T10:00:53+00:00December 25th, 2023|The New York Times|
Can Ozempic and Weight Loss Drugs Treat Other Diseases?news2023-12-20T16:09:05+00:00December 20th, 2023|The New York Times|
New Hope — and an Old Hurdle — for a Terrible Disease With Terrible Treatmentsnews2023-12-19T08:01:00+00:00December 19th, 2023|The New York Times|
¿Un medicamento para que tu perro viva más?news2023-11-30T12:44:11+00:00November 30th, 2023|The New York Times|
Could Longevity Drugs for Dogs Extend Your Pet’s Life?news2023-11-28T05:01:45+00:00November 28th, 2023|The New York Times|
Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.news2023-11-10T10:03:01+00:00November 10th, 2023|The New York Times|
Ending TB Is Within Reach — So Why Are Millions Still Dying?news2023-11-06T10:00:50+00:00November 6th, 2023|The New York Times|
Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patientsnews2023-10-31T21:21:11+00:00October 31st, 2023|The New York Times|
